{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:54:52Z","timestamp":1765727692946},"reference-count":172,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.semarthrit.2008.01.003","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T23:27:11Z","timestamp":1204846031000},"page":"320-335","source":"Crossref","is-referenced-by-count":21,"title":["Assessing the Impact of Psoriatic Arthritis on Patient Function and Quality of Life: Lessons Learned from Other Rheumatologic Conditions"],"prefix":"10.1016","volume":"38","author":[{"given":"Philip J.","family":"Mease","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2008.01.003_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","article-title":"Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis","volume":"45","author":"Husted","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/00015550252948130","article-title":"Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations","volume":"82","author":"Zachariae","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaad.2005.10.008","article-title":"Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective","volume":"54","author":"Mease","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib4","first-page":"1","article-title":"Current estimates from the National Health Interview Survey, 1996","volume":"10","author":"Adams","year":"1999","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1568010043343958","article-title":"Epidemiology of psoriasis","volume":"3","author":"Naldi","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2005.03.046","article-title":"Epidemiology of psoriatic arthritis in the population of the United States","volume":"53","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","article-title":"European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey","volume":"155","author":"Dubertret","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard.60.3.199","article-title":"The national database of the German Collaborative Arthritis Centres: I","volume":"60","author":"Zink","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"suppl 2","key":"10.1016\/j.semarthrit.2008.01.003_bib9","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib10","first-page":"511","article-title":"Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis","volume":"53","author":"Leonard","year":"1978","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2004.06.013","article-title":"Diagnosis and treatment of psoriatic arthritis","volume":"52","author":"Mease","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib12","first-page":"1842","article-title":"Comparison of disability and quality of life in rheumatoid and psoriatic arthritis","volume":"28","author":"Sokoll","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib13","first-page":"439","article-title":"A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis","volume":"13","author":"Husted","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1087-0024.2003.09110.x","article-title":"Quality of life in patients with psoriasis: a systematic literature review","volume":"9","author":"de Korte","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib15","first-page":"280","article-title":"The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey","volume":"137","author":"Krueger","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2133.2003.05492.x","article-title":"Development of the PSORIQOL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials","volume":"149","author":"McKenna","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1468-3083.2000.00085.x","article-title":"The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients","volume":"14","author":"Devrimci-Ozguven","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2133.1998.02511.x","article-title":"Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib20","first-page":"721","article-title":"Employment across chronic inflammatory rheumatic diseases and comparison with the general population","volume":"32","author":"Mau","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.60.10.956","article-title":"Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample","volume":"60","author":"Wiles","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/rheumatology\/39.6.603","article-title":"How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives?","volume":"39","author":"Young","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/art.11197","article-title":"Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis","volume":"49","author":"Ariza-Ariza","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib24","first-page":"1420","article-title":"Predictors of the progression of functional disability in patients with ankylosing spondylitis","volume":"29","author":"Ward","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00296-002-0261-4","article-title":"Functional disability and quality of life in patients with ankylosing spondylitis","volume":"23","author":"Bostan","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004356-199403000-00005","article-title":"Pain and functional limitations in individuals with rheumatoid arthritis","volume":"17","author":"MacKinnon","year":"1994","journal-title":"Int J Rehabil Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/art.20924","article-title":"Physical activity, physical fitness, and general health perception among individuals with rheumatoid arthritis","volume":"53","author":"Eurenius","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.10911","article-title":"Physical activity levels among the general US adult population and in adults with and without arthritis","volume":"49","author":"Hootman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1790110104","article-title":"The stresses of rheumatoid arthritis: appraisals of perceived impact and coping efficacy","volume":"11","author":"Katz","year":"1998","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib30","first-page":"516","article-title":"Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions","volume":"32","author":"Dagfinrud","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib31","first-page":"613","article-title":"Disability and handicap in rheumatoid arthritis and ankylosing spondylitis\u2014results from the German rheumatological database","volume":"27","author":"Zink","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib32","first-page":"639","article-title":"Comparison of self-reported fatigue in rheumatoid arthritis and controls","volume":"22","author":"Belza","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.20910","article-title":"Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures","volume":"53","author":"Dagfinrud","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib34","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/rheumatology\/keg421","article-title":"Assessment of fatigue in the management of patients with ankylosing spondylitis","volume":"42","author":"Dernis-Labous","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib35","first-page":"783","article-title":"Quality of life in rheumatoid arthritis: impact of disability and lifetime depressive spectrum symptomatology","volume":"23","author":"Bazzichi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib36","first-page":"231","article-title":"Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response","volume":"8","author":"Kosinski","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10067-004-0976-6","article-title":"Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36","volume":"24","author":"West","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00296-003-0363-7","article-title":"The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables","volume":"24","author":"Sivas","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10067-006-0298-y","article-title":"A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis","volume":"26","author":"Borman","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.21330","article-title":"Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy","volume":"53","author":"Davis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1529-0131(199908)12:4<247::AID-ART3>3.0.CO;2-H","article-title":"Health-related quality of life in ankylosing spondylitis: a survey of 175 patients","volume":"12","author":"Ward","year":"1999","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10067-005-1150-5","article-title":"Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients","volume":"25","author":"Ozgul","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/art1.10179","article-title":"Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis","volume":"47","author":"van Tubergen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/ard.59.7.549","article-title":"Labour force participation among patients with rheumatoid arthritis","volume":"59","author":"Chorus","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib45","first-page":"328","article-title":"American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines","volume":"46","author":"Kwoh","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib46","first-page":"951","article-title":"Selection of instruments in the core set for DC-ART. SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group Assessments in Ankylosing Spondylitis","volume":"26","author":"van der Heijde","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib47","first-page":"2262","article-title":"Outcome measures in psoriatic arthritis","volume":"32","author":"Gladman","year":"2005","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2008.01.003_bib48","doi-asserted-by":"crossref","first-page":"ii115","DOI":"10.1136\/ard.2004.032615","article-title":"OMERACT 7 psoriatic arthritis workshop: synopsis","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib49","first-page":"1159","article-title":"Outcome measures in psoriatic arthritis","volume":"34","author":"Gladman","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib50","first-page":"1167","article-title":"Consensus on a core set of domains for psoriatic arthritis","volume":"34","author":"Gladman","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib51","first-page":"733","article-title":"International Classification of Functioning","volume":"84","author":"Stucki","year":"2005","journal-title":"Disability, and Health (ICF): a promising framework and classification for rehabilitation medicine Am J Phys Med Rehabil"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2003.019356","article-title":"How to assess the impact of arthritis on the individual patient: the WHO ICF","volume":"64","author":"Stucki","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/09638280400013990","article-title":"ICF Core Set for patients with musculoskeletal conditions in the acute hospital","volume":"27","author":"Stoll","year":"2005","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09638280400014006","article-title":"ICF Core Set for patients with musculoskeletal conditions in early post-acute rehabilitation facilities","volume":"27","author":"Scheuringer","year":"2005","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib55","doi-asserted-by":"crossref","first-page":"ii40","DOI":"10.1136\/ard.2004.028233","article-title":"The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning","volume":"63","author":"Stucki","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00422214","article-title":"International use, application and performance of health-related quality of life instruments","volume":"2","author":"Berzon","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00002281-200203000-00006","article-title":"Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research","volume":"14","author":"Beaton","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib58","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib59","first-page":"S10","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"23","author":"Boers","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib60","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/apmr.2002.36959","article-title":"Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system","volume":"83","author":"Cella","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib61","doi-asserted-by":"crossref","first-page":"MS10","DOI":"10.1097\/00005650-199905001-00002","article-title":"The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability","volume":"37","author":"Kosinski","year":"1999","journal-title":"Med Care"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/rheumatology\/37.4.425","article-title":"Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36)","volume":"37","author":"Ruta","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib63","first-page":"217","article-title":"Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study","volume":"26","author":"Wells","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib64","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s100670200119","article-title":"Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis","volume":"21","author":"Salaffi","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s100670050155","article-title":"How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values?","volume":"19","author":"Birrell","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib66","first-page":"1474","article-title":"The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments","volume":"26","author":"Hagen","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib67","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0149-2918(01)80093-X","article-title":"Psychometric evaluation of the 12-item short-form health survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials","volume":"23","author":"Gandhi","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib68","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/rheumatology\/41.12.1380","article-title":"Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness","volume":"41","author":"Haywood","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-1-20","article-title":"The Stanford Health Assessment Questionnaire: dimensions and practical applications","volume":"1","author":"Bruce","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib71","first-page":"167","article-title":"The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation","volume":"30","author":"Bruce","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jech.34.4.281","article-title":"A quantitative approach to perceived health status: a validation study","volume":"34","author":"Hunt","year":"1980","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib73","first-page":"429","article-title":"A comparison of the sensitivity to change of several health status instruments in rheumatoid arthritis","volume":"20","author":"Fitzpatrick","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/31.2.87","article-title":"A generic health status instrument in the assessment of rheumatoid arthritis","volume":"31","author":"Fitzpatrick","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.2003.006296","article-title":"Development of the PsAQOL: a quality of life instrument specific to psoriatic arthritis","volume":"63","author":"McKenna","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib76","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/rheumatology\/33.7.655","article-title":"Validity of Euroqol\u2014a generic health status instrument\u2014in patients with rheumatoid arthritis","volume":"33","author":"Hurst","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib77","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/rheumatology\/36.5.551","article-title":"Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)","volume":"36","author":"Hurst","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib78","first-page":"1571","article-title":"A comparison of generic, indirect utility measures (the HUI2","volume":"60","author":"Marra","year":"2005","journal-title":"HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQOL and the HAQ) in rheumatoid arthritis Soc Sci Med"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib79","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/rheumatology\/36.7.786","article-title":"Measurement of the quality of life in rheumatic disorders using the EuroQol","volume":"36","author":"Wolfe","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/ard.62.2.140","article-title":"Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis","volume":"62","author":"van Tubergen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib81","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/art.20398","article-title":"Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, short form (WHOQOL-BREF): score distributions and psychometric properties","volume":"51","author":"Taylor","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib82","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Mease","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib83","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib84","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/sj.jid.5700229","article-title":"Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study","volume":"126","author":"Unaeze","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib86","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib87","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/070674378703200506","article-title":"The detection of psychiatric morbidity and associated factors in patients with rheumatoid arthritis","volume":"32","author":"Chandarana","year":"1987","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005650-200101000-00009","article-title":"The Work Limitations Questionnaire","volume":"39","author":"Lerner","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib89","first-page":"1006","article-title":"Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients","volume":"32","author":"Walker","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib90","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/ard.60.10.928","article-title":"Values for function in rheumatoid arthritis: patients, professionals, and public","volume":"60","author":"Hewlett","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib91","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6","article-title":"A reappraisal of HAQ disability in rheumatoid arthritis","volume":"43","author":"Wolfe","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib92","first-page":"557","article-title":"Minimum important difference between patients with rheumatoid arthritis: the patient's perspective","volume":"20","author":"Wells","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib93","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinte.153.11.1337","article-title":"Assessing the clinical importance of symptomatic improvements","volume":"153","author":"Redelmeier","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib94","article-title":"How much improvement in functional status is considered important by patients with active psoriatic arthritis: Applying the outcome measures in rheumatoid arthritis clinical trials (OMERACT) group guidelines","author":"Mease","year":"2004"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib95","article-title":"Health assessment questionnaire has similar psychometric properties in psoriatic arthritis and rheumatoid arthritis","author":"Singh","year":"2005"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib96","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","article-title":"Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format","volume":"42","author":"Pincus","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib97","first-page":"1432","article-title":"Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases","volume":"32","author":"Pincus","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib98","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.1780230203","article-title":"Measuring health status in arthritis","volume":"23","author":"Meenan","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780350102","article-title":"AIMS2","volume":"35","author":"Meenan","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib100","first-page":"2810","article-title":"A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients","volume":"27","author":"Haavardsholm","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib101","first-page":"1932","article-title":"Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis","volume":"23","author":"Husted","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib102","first-page":"1015","article-title":"Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis","volume":"23","author":"Husted","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib103","first-page":"628","article-title":"Development of a functional disability measurement tool to assess early arthritis: the Recent-Onset Arthritis Disability (ROAD) questionnaire","volume":"23","author":"Salaffi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib104","first-page":"S31","article-title":"Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index","volume":"23","author":"Salaffi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib105","first-page":"1709","article-title":"Why not use OSRA?","volume":"25","author":"Birrell","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib106","first-page":"429","article-title":"Development and preliminary assessment of a simple measure of overall status in rheumatoid arthritis (OSRA) for routine clinical use","volume":"88","author":"Symmons","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib107","first-page":"1261","article-title":"Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis","volume":"32","author":"Wolfe","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib108","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/art.10990","article-title":"Development of an instrument to measure disability in parenting activity among women with rheumatoid arthritis","volume":"48","author":"Katz","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib109","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/rheumatology\/36.8.878","article-title":"The reliability and construct validity of the RAQOL: a rheumatoid arthritis-specific quality of life instrument","volume":"36","author":"de Jong","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib110","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/rheumatology\/40.10.1112","article-title":"The validity of the Rheumatoid Arthritis Quality of Life (RAQOL) questionnaire","volume":"40","author":"Tijhuis","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/kei099","article-title":"A simple extension to the Rheumatoid Arthritis Quality of Life Questionnaire (RAQol) to explore individual patient concerns and monitor group outcome in clinical practice","volume":"45","author":"Greenwood","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib112","first-page":"2410","article-title":"A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS\/PAS-II)","volume":"32","author":"Wolfe","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.10915","article-title":"Development of a new instrument for rheumatoid arthritis: the Cedars-Sinai Health-Related Quality of Life instrument (CSHQ-RA)","volume":"49","author":"Weisman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib114","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/art.11478","article-title":"Validation of a rheumatoid arthritis health-related quality of life instrument, the CSHQ-RA","volume":"49","author":"Russak","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.1790080411","article-title":"The impact of rheumatoid arthritis on life activities","volume":"8","author":"Katz","year":"1995","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib116","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/art.1790100204","article-title":"Satisfaction with abilities and well-being: development and validation of a questionnaire for use among persons with rheumatoid arthritis","volume":"10","author":"Katz","year":"1997","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib117","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/ard.2005.044677","article-title":"Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis","volume":"65","author":"Katz","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib118","first-page":"946","article-title":"A modification of the Health Assessment Questionnaire for the spondyloarthropathies","volume":"17","author":"Daltroy","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib119","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard.2004.027185","article-title":"ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis","volume":"64","author":"Sigl","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib120","first-page":"886","article-title":"Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification","volume":"22","author":"Blackmore","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib121","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/1529-0131(199906)12:3<157::AID-ART2>3.0.CO;2-R","article-title":"Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire","volume":"12","author":"Guillemin","year":"1999","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib122","first-page":"302","article-title":"Evaluation of a functional index and an articular index in ankylosing spondylitis","volume":"15","author":"Dougados","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib123","first-page":"689","article-title":"The Dougados Functional Index with the 5-point Likert scale is sensitive to change due to intensive physiotherapy and exercise in spondyloarthropathy","volume":"20","author":"Heikkila","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib124","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00002060-200206000-00004","article-title":"Assessment of functional ability in younger and older patients with ankylosing spondylitis: performance of the bath ankylosing spondylitis functional index","volume":"81","author":"Falkenbach","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib125","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib126","first-page":"975","article-title":"Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity","volume":"26","author":"Calin","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib127","first-page":"1959","article-title":"Comparative responsiveness of 3 functional indices in ankylosing spondylitis","volume":"26","author":"Ruof","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib128","first-page":"961","article-title":"A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib129","first-page":"979","article-title":"Measuring disability in ankylosing spondylitis: comparison of bath ankylosing spondylitis functional index with revised Leeds Disability Questionnaire","volume":"29","author":"Eyres","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib130","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/1529-0131(199806)41:6<1119::AID-ART20>3.0.CO;2-0","article-title":"Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis","volume":"41","author":"Taylor","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib131","first-page":"80","article-title":"Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study","volume":"32","author":"Pavy","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib132","article-title":"Clinically meaningful changes in functional status in patients with ankylosing spondylitis receiving etanercept (Enbrel\u00ae) or placebo","author":"Singh","year":"2005"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib133","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Development of the ASQOL: a quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib134","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/rheumatology\/41.11.1295","article-title":"Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness","volume":"41","author":"Haywood","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib135","first-page":"764","article-title":"Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index","volume":"30","author":"Haywood","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib136","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib137","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2133.2006.07237.x","article-title":"Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial","volume":"154","author":"Reich","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib138","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archderm.141.1.31","article-title":"Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis","volume":"141","author":"Menter","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib139","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1365-2133.2005.06948.x","article-title":"Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial","volume":"153","author":"Krueger","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib140","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1365-2133.2005.06510.x","article-title":"Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial","volume":"152","author":"Feldman","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib141","first-page":"27","article-title":"Impact of efalizumab on psoriasis-specific patient-reported outcomes","volume":"3","author":"Menter","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib142","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2133.2004.05697.x","article-title":"Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis","volume":"150","author":"Feldman","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib143","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1477-7525-1-53","article-title":"Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials","volume":"1","author":"Shikiar","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib144","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2133.1997.tb14896.x","article-title":"Dermatology quality of life scales\u2014a measure of the impact of skin diseases","volume":"136","author":"Morgan","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00128071-200304020-00005","article-title":"Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial","volume":"4","author":"Ellis","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib146","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000069942","article-title":"Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis","volume":"206","author":"Finlay","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib147","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/247553030309a00205","article-title":"The Koo-Menter instrument for identification of psoriasis patients requiring systemic therapy","volume":"9","author":"Koo","year":"2003","journal-title":"Natl Psoriasis Found Psoriasis Forum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib148","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2230.1987.tb01844.x","article-title":"Psoriasis\u2014an index of disability","volume":"12","author":"Finlay","year":"1987","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib149","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2340\/0001555575240243","article-title":"The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress","volume":"75","author":"Gupta","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib150","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-2133.2000.03418.x","article-title":"The Salford Psoriasis Index: an holistic measure of psoriasis severity","volume":"142","author":"Kirby","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib151","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2133.1990.tb04192.x","article-title":"Validation of sickness impact profile and psoriasis disability index in psoriasis","volume":"123","author":"Finlay","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib152","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.1997.tb01113.x","article-title":"Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress","volume":"137","author":"Fortune","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib153","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mjd.2001.114592","article-title":"Physical and psychologic measures are necessary to assess overall psoriasis severity","volume":"45","author":"Kirby","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib154","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/ard.2003.006775","article-title":"Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients","volume":"63","author":"Feletar","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib155","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/art.20335","article-title":"Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression","volume":"50","author":"Mease","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib156","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/ard.2005.040196","article-title":"Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis","volume":"65","author":"Kavanaugh","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib157","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2006.057901","article-title":"Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial","volume":"66","author":"Gladman","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib158","first-page":"322","article-title":"Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATE","volume":"79","author":"Frankel","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib159","first-page":"2146","article-title":"Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis","volume":"25","author":"Husted","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib160","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.20253","article-title":"Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial","volume":"50","author":"Kaltwasser","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib161","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2004.024463","article-title":"A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis","volume":"64","author":"Fraser","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib162","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"issue":"suppl","key":"10.1016\/j.semarthrit.2008.01.003_bib163","first-page":"P2","article-title":"Sustained improvements in patient-reported outcomes in psoriatic arthritis patients treated with etanercept [abstract P5]","volume":"52","author":"Mease","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib164","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.20967","article-title":"Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)","volume":"52","author":"Antoni","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib165","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Mease","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib166","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11136-004-4773-0","article-title":"Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF)","volume":"14","author":"Cieza","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib167","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib168","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1529-0131(199906)12:3<163::AID-ART3>3.0.CO;2-Z","article-title":"Short-form Arthritis Impact Measurement Scales 2: tests of reliability and validity among patients with osteoarthritis","volume":"12","author":"Ren","year":"1999","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib169","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/ard.2003.014522","article-title":"Sensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain","volume":"63","author":"Taal","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib170","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/rheumatology\/41.11.1295","article-title":"Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness","volume":"41","author":"Haywood","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib171","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","article-title":"The Bath Ankylosing Spondylitis Patient Global Score (BAS-G)","volume":"35","author":"Jones","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.01.003_bib172","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000091251","article-title":"Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study","volume":"212","author":"Nash","year":"2006","journal-title":"Dermatology"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T07:40:01Z","timestamp":1708674001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017208000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":172,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0049017208000048"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2008.01.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}